Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach

COVID-19 has emerged as a rapidly escalating serious global health issue, affecting every section of population in a detrimental way. Present situation invigorated researchers to look for potent targets, development as well as repurposing of conventional therapeutic drugs. NSP12, a RNA polymerase, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Sanjay Kumar, Upadhyay, Atul Kumar, Reddy, M. Sudhakara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826501/
https://www.ncbi.nlm.nih.gov/pubmed/33520579
http://dx.doi.org/10.1007/s13205-020-02610-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826501/
https://www.ncbi.nlm.nih.gov/pubmed/33520579
http://dx.doi.org/10.1007/s13205-020-02610-w

Ejemplares similares